|
Volumn 32, Issue 10, 2017, Pages 1495-1497
|
Erratum to: A novel, in-frame KMT2B deletion in a patient with apparently isolated, generalized dystonia (Movement Disorders, (2017), 32, 10, (1495-1497), 10.1002/mds.27137);A novel, in-frame KMT2B deletion in a patient with apparently isolated, generalized dystonia
a a,b a a,b a,b c a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLINERGIC RECEPTOR BLOCKING AGENT;
LYSINE;
LYSINE METHYLTRANSFERASE 2B;
METHYLTRANSFERASE;
UNCLASSIFIED DRUG;
HISTONE LYSINE METHYLTRANSFERASE;
KMT2B PROTEIN, HUMAN;
CASE REPORT;
CHILD;
CLINICAL ARTICLE;
FEMALE;
GENE DELETION;
GENERALIZED DYSTONIA;
HUMAN;
INFORMED CONSENT;
LABORATORY TEST;
LETTER;
MEDICAL EXAMINATION;
MICROCEPHALY;
MYOCLONUS;
PRIORITY JOURNAL;
SCHOOL CHILD;
SCOLIOSIS;
WHOLE EXOME SEQUENCING;
DNA MUTATIONAL ANALYSIS;
DYSTONIA;
GENETICS;
CHILD;
DNA MUTATIONAL ANALYSIS;
DYSTONIA;
FEMALE;
HISTONE-LYSINE N-METHYLTRANSFERASE;
HUMANS;
SEQUENCE DELETION;
|
EID: 85031309407
PISSN: 08853185
EISSN: 15318257
Source Type: Journal
DOI: 10.1002/mds.27254 Document Type: Erratum |
Times cited : (14)
|
References (7)
|